Gyre Therapeutics Statistics
NASDAQ: GYREHealth CareBiotechnology: Pharmaceutical PreparationsUSD
7.04+0.28 (+4.14%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Gyre Therapeutics by the numbers
Gyre Therapeutics has a market capitalization of $746.5 million based on 106.03M shares outstanding. With trailing EPS of $-0.26, Gyre Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 3.3% above its 50-day average and 0.5% below its 200-day average.
Average daily trading volume is 105.93K shares, or about $745,754 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
GYRE valuation vs. peer median
| Metric | GYRE | Peer median | Difference |
|---|---|---|---|
| Market cap | $746.48M | $753.22M | -1% |
| Avg. volume | 105.93K | 1.94M | -95% |
Peer median across 8 companies: VSTM, LXRX, IVA, ANNX, AVTX, DSGN, IMMX, GERN.
Valuation
- Market cap
- $746.48M
- Forward P/E
- 117.33
- EPS (TTM)
- $-0.26
- Shares outstanding
- 106.03M
Price and trading
- Previous close
- 6.76
- Open
- 6.80
- Day range
- 6.76 – 7.09
- 52-week range
- 5.44 – 9.42
- 52-week change
- -1.54%
- Beta
- —
- Volume
- 76.63K
- Average volume
- 105.93K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 6, 2026
Additional statistics
- Market Cap
- 746.48M
- Forward Pe
- 117.33
- Eps
- -0.26
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 9.42
- Week52 Low
- 5.44
- Avg Volume
- 105.93K
- Shares Outstanding
- 106.03M
- Ma50
- 6.82
- Ma200
- 7.07
- Earnings Date
- Nov 6, 2026
- Pct From52w High
- -25.27%
- Pct From52w Low
- 29.41%